Repros Therapeutics Inc (RPRX)

[dewophile]

one more thing. you and i and certainly the market would prefer if there was an SPA, even at a cost of a few months to negotiate and maybe 1 year in trial length to meet a more stringent safety hurdle, but lets not forget this is a real unmet need (especially endo with limited options and pts exposed to surgeries and narcotics galore) - its why the FDA left the door open for asoprisnil, and why i feel in my gut the FDA WANTS this or some other drug in the class available in the clinic